Literature DB >> 25910567

Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology: a meta-analysis of cohort studies.

Jiabi Qin1, Hua Wang2, Xiaoqi Sheng3, Desheng Liang4, Hongzhuan Tan5, Jiahui Xia4.   

Abstract

OBJECTIVE: To provide an up-to-date comparison of pregnancy-related complications and adverse pregnancy outcomes of multiple pregnancies generated with assisted reproductive technology (ART) vs. spontaneous conception.
DESIGN: Meta-analysis.
SETTING: University-affiliated teaching hospital. PATIENT(S): Multiple pregnancies conceived by ART or naturally. INTERVENTION(S): Searches through October 2014 were conducted on PubMed, Google Scholar, Cochrane Libraries, China Biology Medicine disc, Chinese Scientific Journals Fulltext Database, China National Knowledge Infrastructure, and Wanfang Data, to identify studies that met prestated inclusion criteria. Either a fixed- or a random-effects model was used to calculate the overall combined risk estimates. Subgroup analysis was performed to explore potential heterogeneity moderators. MAIN OUTCOME MEASURE(S): Pregnancy-related complications and adverse pregnancy outcomes. RESULT(S): Thirty-nine cohort studies involving 146,008 multiple births were included in the meta-analysis. Multiple pregnancies from ART were associated with a higher risk of premature rupture of membranes (relative risk [RR] = 1.20, 95% confidence interval [CI]: 1.05-1.37; I(2) = 15%); pregnancy-induced hypertension (RR = 1.11, 95% CI: 1.04-1.19; I(2) = 6%); gestational diabetes mellitus (RR = 1.78, 95% CI: 1.25-2.55; I(2) = 42%); preterm birth (RR = 1.08, 95% CI: 1.03-1.14; I(2) = 83%); very preterm birth (RR = 1.18, 95% CI: 1.04-1.34; I(2) = 79%); low birth weight (RR = 1.04, 95% CI: 1.01-1.07; I(2) = 47%); very low birth weight (RR = 1.13, 95% CI: 1.01-1.25; I(2) = 62%); and congenital malformation (RR = 1.11, 95% CI: 1.02-1.22; I(2) = 30%). The relevant heterogeneity moderators have been identified by subgroup analysis. Sensitivity analysis yielded similar results. No evidence of publication bias was observed. CONCLUSION(S): Although the role of potential bias and evidence of heterogeneity should be carefully evaluated, the present study suggests that multiple pregnancies generated via ART, vs. spontaneous conception, are associated with higher risks of pregnancy-related complications and adverse pregnancy outcomes. Further research is needed to determine which aspect of ART poses the most risk and how this risk can be minimized.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technology; adverse pregnancy outcomes; intracytoplasmic sperm injection; in vitro fertilization; meta-analysis

Mesh:

Year:  2015        PMID: 25910567     DOI: 10.1016/j.fertnstert.2015.03.018

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  36 in total

1.  Guidance for elective single-embryo transfer should be applied to frozen embryo transfer cycles.

Authors:  Melanie R Freeman; M Shaun Hinds; Kay G Howard; Julie M Howard; George A Hill
Journal:  J Assist Reprod Genet       Date:  2019-03-11       Impact factor: 3.412

Review 2.  In Vitro Fertilization Technology and Child Health.

Authors:  Michael von Wolff; Thomas Haaf
Journal:  Dtsch Arztebl Int       Date:  2020-01-17       Impact factor: 5.594

3.  Failure of fertility therapy and subsequent adverse cardiovascular events.

Authors:  Jacob A Udell; Hong Lu; Donald A Redelmeier
Journal:  CMAJ       Date:  2017-03-13       Impact factor: 8.262

4.  Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-25       Impact factor: 8.661

5.  Gestational Diabetes in Twin Versus Singleton Pregnancies With Normal Weight or Overweight Pre-Pregnancy Body Mass Index: The Mediating Role of Mid-Pregnancy Weight Gain.

Authors:  Michelle C Dimitris; Jay S Kaufman; Lisa M Bodnar; Robert W Platt; Katherine P Himes; Jennifer A Hutcheon
Journal:  Epidemiology       Date:  2022-03-01       Impact factor: 4.822

6.  Reproductive Outcomes of Single Embryo Transfer in Women with Previous Cesarean Section.

Authors:  Ting Chen; Bo Li; Hao Shi; Zhi Qin Bu; Fu Qing Zhang; Ying Chun Su
Journal:  Reprod Sci       Date:  2020-10-13       Impact factor: 3.060

7.  Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.

Authors:  Costas Thomopoulos; George Salamalekis; Konstantinos Kintis; Iliana Andrianopoulou; Helena Michalopoulou; George Skalis; Stefanos Archontakis; Ourania Argyri; Costas Tsioufis; Thomas K Makris; Emmanuel Salamalekis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

8.  Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses.

Authors:  Hui Ju Chih; Flavia T S Elias; Laura Gaudet; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-28       Impact factor: 3.007

9.  Obstetrical outcomes of ART pregnancies in patients with male factor infertility.

Authors:  Isca Landesberg; Anat Lavie; Maya Ram; Michal Yechieli; Lee Reicher; Ariel Many; Sharon Morag; Yonit Schechtman
Journal:  J Assist Reprod Genet       Date:  2021-06-17       Impact factor: 3.357

10.  Assisted reproductive technology and birth defects in a Chinese birth cohort study.

Authors:  Hong Lv; Feiyang Diao; Jiangbo Du; Ting Chen; Qingxia Meng; Xiufeng Ling; Hong Li; Ci Song; Qi Xi; Yangqian Jiang; Yan Xu; Shiyao Tao; Lei Huang; Mingyang Wen; Meijuan Peng; Cong Liu; Qun Lu; Yuanlin He; Yin Yin; Xiaoyu Liu; Bo Xu; Xiumei Han; Kun Zhou; Tao Jiang; Yang Zhao; Hongxia Ma; Guangfu Jin; Yankai Xia; Jiayin Liu; Yuan Lin; Zhibin Hu; Hongbing Shen
Journal:  Lancet Reg Health West Pac       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.